A genetic breakthrough reveals why mental health conditions often occur together. New research identifies five disorder ...
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...
Emerging evidence suggests that the ketogenic diet can significantly reduce symptoms associated with depression. The keto ...
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...
A new study led by the University of Miami Miller School of Medicine's Kirill Martemyanov, Ph.D., and international ...
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
Zuranolone is a novel, rapidly acting, oral medication for the treatment of postpartum depression. Zuranolone is generally ...
Patients with depressive symptoms and asthma had elevated levels of serum brain-derived neurotrophic factor in association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results